Wall Street Unplugged
Episode: 338August 21, 2015

Here’s the Next Company That Will Cut Its Dividend

Marc-LichtenfeldWelcome back to another episode of Wall Street Unplugged!

This week, my guest, Marc Lichtenfeld, chief income strategist at the Oxford Club and editor of the Oxford Income Letter, shares a simple formula investors can use to determine if a dividend is safe.

This is important since many companies – notably in the energy sector – are suspending their dividends.  He also recommends two of his favorite dividend paying stocks to buy right now.  

Marc then explains why speculative stocks are suitable for almost any portfolio.  He shows investors – by using a four-rule system – how to find these potential 5-baggers without taking huge risks.  

Finally, Marc breaks down the biotech industry.  This is a sector of the market he’s been covering for almost a decade.  Marc suggests investors should be buying biotech stocks on the recent pullback.

However, he explains why one particular area within the sector should be avoided at all costs.

As always, thanks for listening and good investing!

What’s really moving these markets?
Get free daily updates
More Wall Street Unplugged
Donald Trump

Trump’s win will benefit these sectors

These sectors will surge under Trump… Time to sell solar stocks? … Financial stocks to buy and sell… Buy this crypto stock… Why Europe, China, and gold are selling off… Will oil stocks plummet? … And more interest rate cuts?

Starbucks Coffee

Is Starbucks uninvestable?

Election predictions: The betting markets vs. the media… Why is this billionaire avoiding fixed income? … Gold, Bitcoin, and bonds are all saying the same thing about inflation… Is Starbucks (SBUX) uninvestable? … And GM (GM) is poised to soar.

Healthcare

Buy this healthcare stock before December 4

The best election outcome for stocks… How Polymarket is different from other polls… Big tech's transition to nuclear power… What earnings are saying about a banking crisis… What ASML's (ASML) plunge means for semiconductors… And a screaming buy in healthcare.